Previously, we had identified a recombinant bacteriophage from a lgt11 gene library which expressed an immunogenic Mycobacterium kansasii antigen (MK35). We had also demonstrated that MK35 is reactive against sera from patients with mycobacterial disease and evokes a large skin test response in sensitized guinea pigs. In FY92, we have completed the DNA sequence of the gene encoding MK35. Nucleotide sequence analysis has indicated that MK35 is a 26 kDa lipoprotein. Using polymerase chain reaction methodologies, we have identified homologous genes from M. tuberculosis and M. avium. These genes are currently being characterized.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BA005003-04
Application #
3792341
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost